175 related articles for article (PubMed ID: 15772145)
21. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
Robin AL; Novack GD; Covert DW; Crockett RS; Marcic TS
Am J Ophthalmol; 2007 Oct; 144(4):533-40. PubMed ID: 17686450
[TBL] [Abstract][Full Text] [Related]
22. [Anti-tuberculosis chemotherapy].
Wada M
Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
[TBL] [Abstract][Full Text] [Related]
23. Optimal drug treatment regimens for HIV depend on adherence.
Krakovska O; Wahl LM
J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
[TBL] [Abstract][Full Text] [Related]
24. The science and marketing of simpler dosing.
Proj Inf Perspect; 1997 Nov; (23):6-7. PubMed ID: 11365380
[TBL] [Abstract][Full Text] [Related]
25. Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.
Winston A; Bloch M; Carr A; Amin J; Mallon PW; Ray J; Marriott D; Cooper DA; Emery S
J Antimicrob Chemother; 2005 Aug; 56(2):380-7. PubMed ID: 15996972
[TBL] [Abstract][Full Text] [Related]
26. [Assessment of factors associated with patients' comprehension of treatment at the start of antiretroviral therapy].
Braga Ceccato Md; Acurcio Fde A; Vallano A; Comini César C; Crosland Guimarães MD
Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):7-13. PubMed ID: 19217997
[TBL] [Abstract][Full Text] [Related]
27. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories.
Blaschke TF; Osterberg L; Vrijens B; Urquhart J
Annu Rev Pharmacol Toxicol; 2012; 52():275-301. PubMed ID: 21942628
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya.
Talam NC; Gatongi P; Rotich J; Kimaiyo S
East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414
[TBL] [Abstract][Full Text] [Related]
29. Dosing regimens: what's it all about, Alfie?
Res Initiat Treat Action; 1998 Feb; 4(1):15. PubMed ID: 11365216
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
31. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
Cuzin L; Allavena C; Morlat P; Dellamonica P
AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
[TBL] [Abstract][Full Text] [Related]
32. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
Glass TR; De Geest S; Hirschel B; Battegay M; Furrer H; Covassini M; Vernazza PL; Bernasconi E; Rickenboch M; Weber R; Bucher HC;
Antivir Ther; 2008; 13(1):77-85. PubMed ID: 18389901
[TBL] [Abstract][Full Text] [Related]
33. Benefits and concerns of simplification strategies in HIV-infected patients.
Negredo E; Bonjoch A; Clotet B
J Antimicrob Chemother; 2006 Aug; 58(2):235-42. PubMed ID: 16807250
[TBL] [Abstract][Full Text] [Related]
34. New approaches to the treatment of latent tuberculosis.
Sterling TR
Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
[TBL] [Abstract][Full Text] [Related]
35. Long-distance interactive expert advice in highly treatment-experienced HIV-infected patients.
Llibre JM; Domingo P; del Pozo MA; Miralles C; Galindo MJ; Viciana I; Moreno S; Schapiro JM; Clotet B
J Antimicrob Chemother; 2008 Jan; 61(1):206-9. PubMed ID: 17999972
[TBL] [Abstract][Full Text] [Related]
36. New anti-tuberculosis drugs in clinical trials with novel mechanisms of action.
Rivers EC; Mancera RL
Drug Discov Today; 2008 Dec; 13(23-24):1090-8. PubMed ID: 18840542
[TBL] [Abstract][Full Text] [Related]
37. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin.
Vrijens B; Belmans A; Matthys K; de Klerk E; Lesaffre E
Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):115-21. PubMed ID: 16342302
[TBL] [Abstract][Full Text] [Related]
38. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
[TBL] [Abstract][Full Text] [Related]
39. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals.
Lima VD; Harrigan R; Murray M; Moore DM; Wood E; Hogg RS; Montaner JS
AIDS; 2008 Nov; 22(17):2371-80. PubMed ID: 18981777
[TBL] [Abstract][Full Text] [Related]
40. A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study.
Torti C; Quiros-Roldan E; Regazzi M; De Luca A; Mazzotta F; Antinori A; Ladisa N; Micheli V; Orani A; Patroni A; Villani P; Lo Caputo S; Moretti F; Di Giambenedetto S; Castelnuovo F; Maggi P; Tinelli C; Carosi G;
Clin Infect Dis; 2005 Jun; 40(12):1828-36. PubMed ID: 15909273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
